Jiangsu Aidea Pharmaceutical Co (SHSE:688488) Days Sales Outstanding : 192.98 (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Jiangsu Aidea Pharmaceutical Co Days Sales Outstanding?

Jiangsu Aidea Pharmaceutical Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥196.5 Mil. Jiangsu Aidea Pharmaceutical Co's Revenue for the three months ended in Mar. 2024 was ¥92.9 Mil. Hence, Jiangsu Aidea Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 192.98.

The historical rank and industry rank for Jiangsu Aidea Pharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

SHSE:688488' s Days Sales Outstanding Range Over the Past 10 Years
Min: 91.41 Med: 130.02 Max: 178.25
Current: 178.25

During the past 8 years, Jiangsu Aidea Pharmaceutical Co's highest Days Sales Outstanding was 178.25. The lowest was 91.41. And the median was 130.02.

SHSE:688488's Days Sales Outstanding is ranked worse than
81.53% of 888 companies
in the Biotechnology industry
Industry Median: 72.545 vs SHSE:688488: 178.25

Jiangsu Aidea Pharmaceutical Co's Days Sales Outstanding increased from Mar. 2023 (121.39) to Mar. 2024 (192.98).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Jiangsu Aidea Pharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for Jiangsu Aidea Pharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Aidea Pharmaceutical Co Days Sales Outstanding Chart

Jiangsu Aidea Pharmaceutical Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

155.27

172.48

128.43

128.60

131.43

Jiangsu Aidea Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															121.39	146.20	274.24	141.96	192.98

Competitive Comparison of Jiangsu Aidea Pharmaceutical Co's Days Sales Outstanding

For the Biotechnology subindustry, Jiangsu Aidea Pharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jiangsu Aidea Pharmaceutical Co's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jiangsu Aidea Pharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Jiangsu Aidea Pharmaceutical Co's Days Sales Outstanding falls into.

Jiangsu Aidea Pharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Jiangsu Aidea Pharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (113.829	+	182.416)	/	2 )	/	411.364	*	365
=	148.1225					/	411.364	*	365
=	131.43

Jiangsu Aidea Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (182.416	+	210.49)	/	2 )	/	92.894	*	365 / 4
=	196.453					/	92.894	*	365 / 4
=	192.98

Jiangsu Aidea Pharmaceutical Co (SHSE:688488) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Jiangsu Aidea Pharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Jiangsu Aidea Pharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Aidea Pharmaceutical Co (SHSE:688488) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Aidea Pharmaceutical Co Ltd (SHSE:688488) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 2 Liuzhuang Road, Hanjiang District, Jiangsu Province, Yangzhou, CHN, 225008

Website

http://www.aidea.com.cn

Jiangsu Aidea Pharmaceutical Co Ltd produces and sells human-derived protein products, and also develops some generic drug businesses and distributes Abbott's HIV diagnostic equipment and reagents. The company focuses on development of new chemical entities of anti-tumor, anti-virus and cardiovascular areas, among which two NCE drugs for the treatment of Cancer and AIDS have been approved.

Executives

Yuan Yu	Core technical personnel
Fu He Liang	Director, core technical staff
Su Gu Fang	Core technical personnel
Zhang Ji Bing	Core technical personnel
Wang Jun	Directors, senior managers
Wang Guang Rong	Directors, senior managers
Yu Ke	Directors, senior managers

Jiangsu Aidea Pharmaceutical Co (SHSE:688488) Headlines

No Headlines